Jaap Jan Boelens

ORCID iD
https://orcid.org/0000-0003-2232-6952
  • Country
  • Show details Hide details
Netherlands

Sources:
Jaap Jan Boelens (2016-01-24)

  • Keywords
  • Show details Hide details
PKPD,

Sources:
Jaap Jan Boelens (2016-01-26)

Inborn Error of Metabolism,

Sources:
Jaap Jan Boelens (2016-01-26)

Hematopoietic Cell Transplantation,

Sources:
Jaap Jan Boelens (2016-01-26)

Cell Therapy,

Sources:
Jaap Jan Boelens (2016-01-26)

Cord Blood,

Sources:
Jaap Jan Boelens (2016-01-26)

Immune reconstitution,

Sources:
Jaap Jan Boelens (2016-01-26)

AML

Sources:
Jaap Jan Boelens (2016-01-26)

  • Websites
  • Show details Hide details
http://www.tumor-immunology-utrecht.nl

Sources:
Jaap Jan Boelens (2016-01-26)

Tri TAA-specific cord blood DC vaccin neuroblastoma project

Sources:
Jaap Jan Boelens (2016-06-24)

WT1 cord blood DC vaccin (AML project)

Sources:
Jaap Jan Boelens (2016-06-24)

  • Email
  • Show details Hide details

Sources:
0000-0003-2232-6952 (2014-01-15)

Sources:
Jaap Jan Boelens (2016-01-27)

  • Other IDs
  • Show details Hide details
Scopus Author ID: 14014030800

Sources:
Scopus to ORCID (2016-01-26)

Biography

Pediatrician – Oncologist / Immunologist. Medicine (UMC Utrecht 1996), PhD in Amsterdam (University of Amsterdam/Academic Medical Center; 1999), trained as a paediatrician in Leiden (Leiden UMC)/Den Haag; Juliana Children’s Hospital; 2004) followed by completion of clinical fellowship in immunology (2006; UMC Utrecht) and oncology (2011; ErasmusMC, Rotterdam). My clinical sub-specialization is Hemapoietic Cell Transplantation (HCT) and I am working as a consultant in HCT at the UMC Utrecht since 2006. I have a special interest in rare-diseases (as indication for HCT) in particular “lysosomal storage diseases” and finding strategies to get better disease control (in malignant diseases). My research group (Group Boelens / Nierkens: U-DANCE) focuses on the development of cord blood derived dendritic cell vaccines (anti-AML, anti-Neuroblastoma). In addition there is a special interest designing a predictable low toxic conditioning regimen using PK/PD-models for e.g. ATG (anti-thymocyte globuline) to better predict the immune-reconstitution (nessasary for optimal effect vaccines). 4 PostDocs, 5 PhD students and 2 technicians are working in my group.
  • : , ,

    {{group.getActive().startDate.year}}-{{group.getActive().startDate.month}}-{{group.getActive().startDate.day}} to present {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}} {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}} |  ()
    • Show Details Hide Details
    Organization identifiers
    {{group.getActive().orgDisambiguatedName}}: {{group.getActive().orgDisambiguatedCity}}, {{group.getActive().orgDisambiguatedRegion}}, {{group.getActive().orgDisambiguatedCountry}}
    Other organization identifiers provided by {{group.getActive().disambiguationSource.value}}
    • {{orgDisambiguatedExternalIdentifier.identifierType}}: {{orgDisambiguatedExternalIdentifier.preferred}} (preferred), {{orgDisambiguatedExternalIdentifierAll}}{{$last ? '' : ', '}}
    Created
    Source: {{(group.getActive().sourceName == null || group.getActive().sourceName == '') ? group.getActive().source : group.getActive().sourceName}}
No education added yet
  • : , ,

    {{group.getActive().startDate.year}}-{{group.getActive().startDate.month}}-{{group.getActive().startDate.day}} to present {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}} {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}} |  ()
    • Show Details Hide Details
    Organization identifiers
    {{group.getActive().orgDisambiguatedName}}: {{group.getActive().orgDisambiguatedCity}}, {{group.getActive().orgDisambiguatedRegion}}, {{group.getActive().orgDisambiguatedCountry}}
    Other organization identifiers provided by {{group.getActive().disambiguationSource.value}}
    • {{orgDisambiguatedExternalIdentifier.identifierType}}: {{orgDisambiguatedExternalIdentifier.preferred}} (preferred), {{orgDisambiguatedExternalIdentifierAll}}{{$last ? '' : ', '}}
    Created
    Source: {{(group.getActive().sourceName == null || group.getActive().sourceName == '') ? group.getActive().source : group.getActive().sourceName}}
No employment added yet
No Funding added yet
No publications added yet